Inventiva S.A. American Depository Shares (IVA) vs Obsidian Therapeutics (OBX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Inventiva S.A. American Depository Shares is the larger company by market cap ($750.8 million vs $741.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IVA | OBX |
|---|---|---|
| Share price | $3.14 | $12.00 |
| Market cap | $750.78M | $741.29M |
| 1-day change | -8.99% | -1.23% |
| YTD return | -32.47% | — |
| 1-year return | -26.98% | — |
| 5-year return | -76.53% | — |
| EPS (TTM) | $-0.62 | $-6.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-49.63M | — |
| 52-week high | $7.29 | $49.97 |
| 52-week low | $2.82 | $9.60 |
| Distance from 52-week high | -56.93% | -75.99% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +359.24% | +222.25% |
| Average volume | 2.40M | 511.50K |
| Shares outstanding | 239.10M | 61.77M |
| Employees | 87 | 87 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Inventiva S.A. American Depository Shares
IVA stock →Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
About Obsidian Therapeutics
OBX stock →Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
IVA vs OBX FAQ
Which is bigger, Inventiva S.A. American Depository Shares or Obsidian Therapeutics?
Inventiva S.A. American Depository Shares (IVA) is larger, with a market capitalization of $750.78M compared with $741.29M for Obsidian Therapeutics (OBX).
Are Inventiva S.A. American Depository Shares and Obsidian Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.